# Imobisoft

> Imobisoft is a reviewed AI agency in London, United Kingdom, listed in the AIAgencies.eu register and last assessed 2026-09-04.

Canonical page: https://www.aiagencies.eu/agency/imobisoft
Generated: 2026-09-24 · Curated by Gabor Kiss · No paid placements — inclusion, score, and rank are never sold.

## Facts
- Location: London, United Kingdom
- Website: https://imobisoft.co.uk
- Hourly rate: €45-85/hr (directory-listed)
- Team size: 10-49
- Founded: 2009
- Services: AI Consulting, AI Development, Generative AI
- Industries: Healthcare, Manufacturing, E-commerce
- LinkedIn: https://www.linkedin.com/company/imobisoft

## About
Imobisoft is a Coventry AI and software developer, with a London office, building diagnostic platforms, risk-assessment systems and language-model applications for health and industrial clients.

## Documented clients
Documented engagements: MirZyme Therapeutics, Hydraclean, Don't Waste Money, Lugmety, GSK, Sky, SABIC, BBC, Dunelm, and Northern Gas Networks. 4 of 10 carry a source URL on file.

## Curator assessment
Reviewed 2026-09-04 by Gabor Kiss against published evidence.

Two named clients, two systems in operational use: the M-PREG platform built for MirZyme Therapeutics scores preeclampsia risk at a stated 93% diagnostic accuracy and carries UKCA marking, and Hydraclean's Legionella compliance platform generates structured risk assessments and reports that replaced a paper inspection process.

A third study describes two models for an unnamed petrochemical company—one analyzing competitors' published sustainability reports, one predicting how single indicator changes move a Bloomberg ESG score.

What none of the three gives you is technical detail: "cloud-based risk algorithm" and "AI analyses risk factors" is the level throughout, with no model families, validation methodology or monitoring described, and 21 further case studies sit unread behind the six the index surfaces.

The weaker fit is a buyer who needs to interrogate the modeling before committing—for that, the published material stops at the outcome.

### Key strengths
- Regulated-market delivery is evidenced rather than claimed: the diagnostic platform went through conformity assessment, which constrains how the model can change after release
- €45–85/h from a 17-year entity with offices in Coventry and London
- The client wall names GSK, Sky, SABIC, the BBC, Dunelm and Northern Gas Networks—large-account delivery experience to test in the first call

### Good to know
- GSK, Sky and the BBC appear as logos while the published AI studies belong to smaller clients—ask which named account the AI team actually delivered
- The ESG study's client is anonymized and its outcomes are directional rather than numeric—ask for a reference and the measured movement in the score
- Team structure is not published—confirm whether the people who built the regulated diagnostic platform would be on your engagement

---
Source: AIAgencies.eu — the curated register of European AI agencies. Rate provenance: "agency-confirmed" = disclosed via submission or claimed profile; "directory-listed" = Clutch or two agreeing B2B directories (lone unverified sources are never written). Full method: https://www.aiagencies.eu/methodology · Rate index: https://www.aiagencies.eu/rates